We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

134 hedge funds and large institutions have $418M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2015 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 60 increasing their positions, 30 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 30

59% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 17

9% more capital invested

Capital invested by funds: $385M → $418M (+$33M)

6% more funds holding

Funds holding: 127 → 134 (+7)

Holders
134
Holders Change
+7
Holders Change %
+5.51%
% of All Funds
3.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
60
Reduced
30
Closed
17
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$376K

Top Buyers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
+$10.1M
2
HM
HealthCor Management
New York
+$7.87M
3
EAM
EverPoint Asset Management
Connecticut
+$5.51M
4
SAM
Sectoral Asset Management
Quebec, Canada
+$3.54M
5
PCM
Penn Capital Management
Pennsylvania
+$3.41M

Top Sellers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
-$16.8M
2
Franklin Resources
Franklin Resources
California
-$14.2M
3
State Street
State Street
Massachusetts
-$9.98M
4
RIM
Ranger Investment Management
Texas
-$2.72M
5
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado
Colorado
-$2.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
126
Zurich Cantonal Bank
Switzerland
$5K – – –
KC
127
Kingfisher Capital
North Carolina
$5K +$4.69K +298 New
CG
128
Cutler Group
California
$4K +$4.72K +300 New
GT
129
Glenmede Trust
Pennsylvania
$3K – – –
PSC
130
Piper Sandler & Co
Minnesota
$3K +$2.91K +185 New
DADC
131
D.A. Davidson & Co
Montana
$3K +$3.94K +250 New
Creative Planning
132
Creative Planning
Kansas
$2K +$1.57K +100 +5,000%
Fifth Third Bancorp
133
Fifth Third Bancorp
Ohio
$1K +$16 +1 +2%
Manulife (Manufacturers Life Insurance)
134
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$237 – – –
SCM
135
Scopia Capital Management
New York
– -$16.8M -1,098,590 Closed
RIM
136
Ranger Investment Management
Texas
– -$2.72M -177,706 Closed
Public Employees Retirement Association of Colorado
137
Public Employees Retirement Association of Colorado
Colorado
– -$2.35M -153,500 Closed
CCP
138
Clough Capital Partners
Massachusetts
– -$2.22M -145,000 Closed
ACM
139
Asymmetry Capital Management
California
– -$1.41M -92,213 Closed
VIA
140
Vident Investment Advisory
Georgia
– -$583K -38,030 Closed
NG
141
NatWest Group
United Kingdom
– -$480K -31,280 Closed
CIA
142
Capital Impact Advisors
Massachusetts
– -$438K -28,587 Closed
First Trust Advisors
143
First Trust Advisors
Illinois
– -$421K -27,441 Closed
American Century Companies
144
American Century Companies
Missouri
– -$400K -26,124 Closed
DCM
145
Dupont Capital Management
Delaware
– -$332K -21,652 Closed
Susquehanna International Group
146
Susquehanna International Group
Pennsylvania
– -$301K -19,635 Closed
SIM
147
Spark Investment Management
New York
– -$283K -18,500 Closed
PAM
148
Paradigm Asset Management
New York
– -$51.4K -3,350 Closed
DLHL
149
Donald L. Hagan LLC
Florida
– -$13K -834 Closed
TRCT
150
Tower Research Capital (TRC)
New York
– -$3K -224 Closed
3 4 5
6
7

SGNT Hedge Fund Activity: Q4 2015 in Review

134 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q4 2015, worth a combined $418M — up 8.6% from $385M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new SGNT positions and 17 closed out — a net gain of 10 holders — while 60 added to existing stakes and 30 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $10.1M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $16.8M sold.

  • 134 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q4 2015, up from 127 in Q3 2015.
  • Funds reported $418M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q4 2015, up 8.6% quarter-over-quarter.
  • 27 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q4 2015 and 17 closed out, a net change of +10 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2015 was Eagle Asset Management, an estimated $10.1M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q4 2015 was Scopia Capital Management, an estimated $16.8M sold.

Based on aggregated 13F filings for Q4 2015.